EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 24.40
-1.45 (-5.61%)
Sep 25, 2026, 5:15 PM GMT
EKF Diagnostics Holdings Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 51.35 | 51.56 | 50.19 | 52.61 | 66.64 | 81.84 | |
Revenue Growth | 2.26% | 2.73% | -4.59% | -21.05% | -18.57% | 25.40% |
Cost of Revenue | 24.27 | 25.08 | 25.8 | 28.18 | 35.82 | 42.47 |
Gross Profit | 27.08 | 26.48 | 24.4 | 24.44 | 30.81 | 39.37 |
Selling, General & Admin | 15.26 | 14.71 | 13.82 | 14.13 | 16.42 | 11.26 |
Research & Development | 1.44 | 1.44 | 1.35 | 1.82 | 1.52 | 1.38 |
Amortization of Goodwill & Intangibles | 2.26 | 2.26 | 1.04 | 2.07 | 3.5 | 3.79 |
Other Operating Expenses | -0.21 | -0.23 | -0.29 | -0.16 | -0.92 | -0.09 |
Operating Expenses | 20.08 | 19.5 | 17.78 | 19.52 | 22.26 | 17.52 |
Operating Income | 7.01 | 6.98 | 6.61 | 4.91 | 8.55 | 21.84 |
Interest Expense | -0.16 | -0.15 | -0.17 | -0.08 | -0.1 | -0.07 |
Interest & Investment Income | 0.32 | 0.26 | 0.17 | 0.13 | 0.13 | 0.05 |
Other Non Operating Income (Expenses) | - | - | - | - | - | -0.29 |
EBT Excluding Unusual Items | 7.17 | 7.09 | 6.62 | 4.96 | 8.58 | 21.53 |
Merger & Restructuring Charges | - | - | -0.35 | -2.83 | -17.53 | -0.2 |
Other Unusual Items | -0.29 | - | - | - | 0 | 0.11 |
Pretax Income | 6.88 | 7.09 | 6.26 | 2.13 | -8.94 | 21.44 |
Income Tax Expense | 3.97 | 4.56 | -0.31 | -0.6 | 0.63 | 5.28 |
Earnings From Continuing Operations | 2.91 | 2.53 | 6.58 | 2.73 | -9.58 | 16.16 |
Net Income to Company | 2.91 | 2.53 | 6.58 | 2.73 | -9.58 | 16.16 |
Minority Interest in Earnings | -0.42 | -0.41 | -0.34 | -0.38 | -0.53 | -0.31 |
Net Income | 2.5 | 2.12 | 6.24 | 2.35 | -10.1 | 15.85 |
Net Income to Common | 2.5 | 2.12 | 6.24 | 2.35 | -10.1 | 15.85 |
Net Income Growth | -59.18% | -66.00% | 165.39% | - | - | 42.62% |
Shares Outstanding (Basic) | 438 | 448 | 454 | 454 | 457 | 457 |
Shares Outstanding (Diluted) | 438 | 448 | 454 | 454 | 457 | 461 |
Shares Change | -3.25% | -1.19% | -0.08% | -0.67% | -0.82% | 0.47% |
EPS (Basic) | 0.01 | 0.00 | 0.01 | 0.01 | -0.02 | 0.03 |
EPS (Diluted) | 0.01 | 0.00 | 0.01 | 0.01 | -0.02 | 0.03 |
EPS Growth | -57.87% | -65.84% | 165.63% | - | - | 42.16% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 6.2 | 8.18 | 11.41 | -0.29 | 5.25 | 5.9 |
Free Cash Flow Per Share | 0.01 | 0.02 | 0.03 | -0.00 | 0.01 | 0.01 |
Dividend Per Share | - | - | - | 0.012 | 0.012 | 0.012 |
Dividend Growth | - | - | - | 0% | 0% | 9.09% |
Gross Margin | 52.74% | 51.35% | 48.60% | 46.45% | 46.24% | 48.10% |
Operating Margin | 13.64% | 13.53% | 13.17% | 9.34% | 12.84% | 26.69% |
Profit Margin | 4.86% | 4.12% | 12.44% | 4.47% | -15.16% | 19.37% |
Free Cash Flow Margin | 12.07% | 15.86% | 22.73% | -0.55% | 7.89% | 7.21% |
EBITDA | 10.18 | 10.16 | 10.25 | 9.25 | 13.16 | 26.46 |
EBITDA Margin | 19.82% | 19.70% | 20.41% | 17.59% | 19.75% | 32.33% |
D&A For EBITDA | 3.17 | 3.18 | 3.64 | 4.34 | 4.61 | 4.62 |
EBIT | 7.01 | 6.98 | 6.61 | 4.91 | 8.55 | 21.84 |
EBIT Margin | 13.64% | 13.53% | 13.17% | 9.34% | 12.84% | 26.69% |
Effective Tax Rate | 57.65% | 64.28% | - | - | - | 24.62% |